CVS

CVS Health Corp.

Healthcare · $109.7B market cap

Verdict

Share price

$86.46

close of Oct 3, 2026

Fair value

$60.71

Sticker Price

Payback Price

$24.29

buy price

Overpriced

CVS is Overpriced: at $86.46 it trades 42% above its fair value of $60.71. Its buy price (Payback Price) is $24.29, 72% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth6.8% a year✗
Equity per share growth6.1% a year✗
Sales growth10.1% a year✓
Free cash flow growth13.9% a year✓
Return on invested capital4.7%✗

Follow CVS

Get notified when it reaches its buy price of $24.29. Free.

Create a free account

Superinvestors

10 of the investors we track hold CVS. In Q2 2026, 1 opened a position, 3 trimmed and 2 sold out. Who we track

Insider activity

Since Jun 26, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

About CVS Health Corp.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in…

Medical - Healthcare Plans

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works